Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |